Nucynta Tablet, Film Coated
Product Images NDC 24510-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nucynta (NDC 24510-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Collegium Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nucynta 01)

FDA Label Image

Figure 1 (Nucynta 02)

Figure 1 (Nucynta 02)
The text appears to be a chart with medication names and dosages, along with percentage improvement in pain levels. The medications listed are NUCYNTA® in 50mg, 75mg, and 100mg dosages, as well as a placebo. The chart shows the percent of patients improved and percent improvement in pain from baseline at hour 45.*
FDA Label Image

Figure 2 (Nucynta 03)

Figure 2 (Nucynta 03)
This appears to be a graph or table showing the percentage of patients who experienced improvement in pain levels after taking NUCYNTA® at different dosages (50mg and 75mg) compared to a placebo. However, without additional information or context, it is difficult to provide a more comprehensive description.*
FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Principal Display Panel (50 mg Tablet Bottle Label)
This is a description of a medication called NUCYNTA which comes in 100 tablets, each containing tapentadol 50 mg. It is distributed by Collegium Pharmaceutical Inc. and has a National Drug Code (NDC) of 24510-050-10. It warns that transferring the drug to anyone except the patient for whom it was prescribed is prohibited by federal law. The accompanying medication guide must be dispensed to each patient. It is a prescription drug that must be stored between 20°C-25°C (68°F - 77°F) with an excursion permitted up to 15°C - 30°C (59°F - 86°F) and protected from moisture.*
FDA Label Image

Principal Display Panel (75 mg Tablet Bottle Label)

Principal Display Panel (75 mg Tablet Bottle Label)
This is a description for Nucynta, a medication that contains 75mg of tapentadol per tablet, packaged as 100 tablets with the NDC code 24510-075-10. The drug is distributed by Collegium Pharmaceutical, located in Stoughton, MA. The medication guide that accompanies the medication should be dispensed to each patient, and the recommended dosage should be consulted. The drug should be stored at room temperature between 20°C and 25°C (68°F and 77°F) and protected from moisture. This drug is only available with a prescription and should only be transferred to the patient for whom it was prescribed due to federal law.*
FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
NUCYNTA is a prescription drug containing tapentadol in the strength of 100 mg per tablet. It is distributed by Collegium Pharmaceutical, Inc. and comes in a bottle of 100 tablets. Federal law prohibits transferring this drug to anyone other than the patient it was prescribed to, and it comes with a medication guide which must be dispensed to each patient. The dosage and other details can be found in the product literature, and the drug should be stored between 20°C to 25°C (68°F to 77°F) to prevent moisture damage. It is important to keep NUCYNTA out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.